CRISPR Therapeutics (Germany) Price on January 6, 2025
| 1CG Stock | 40.80 0.00 0.00% |
If you're considering investing in CRISPR Stock, it is important to understand the factors that can impact its price. As of today, the current price of CRISPR Therapeutics stands at 40.80, as last reported on the 10th of January, with the highest price reaching 40.80 and the lowest price hitting 40.80 during the day. We have found three technical indicators for CRISPR Therapeutics AG, which you can use to evaluate the volatility of the firm.
CRISPR Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
CRISPR |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| 1CG |
Based on monthly moving average CRISPR Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CRISPR Therapeutics by adding CRISPR Therapeutics to a well-diversified portfolio.
CRISPR Therapeutics Valuation on January 6, 2025
It is possible to determine the worth of CRISPR Therapeutics on a given historical date. On January 6, 2025 CRISPR was worth 40.8 at the beginning of the trading date compared to the closed value of 40.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CRISPR Therapeutics stock. Still, in general, we apply an absolute valuation method to find CRISPR Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CRISPR Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CRISPR Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 40.80 | 40.80 | 40.80 | 40.80 | 1.00 | |
01/06/2025 | 40.80 | 40.80 | 40.80 | 40.80 | 1.00 |
| 40.80 | 40.80 | 40.80 | 40.80 | 1.00 |
| Backtest CRISPR Therapeutics | | | CRISPR Therapeutics History | | | CRISPR Therapeutics Valuation | Previous | Next |
CRISPR Therapeutics Trading Date Momentum on January 6, 2025
| On January 07 2025 CRISPR Therapeutics AG was traded for 40.80 at the closing time. The highest price during the trading period was 40.80 and the lowest recorded bid was listed for 40.80 . There was no trading activity during the period 1.0. Lack of trading volume on January 7, 2025 did not affect price variability. The overall trading delta to the current price is 0.00% . |
CRISPR Therapeutics Fundamentals Correlations and Trends
By evaluating CRISPR Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CRISPR Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CRISPR financial account trend analysis is a perfect complement when working with valuation or volatility modules.About CRISPR Therapeutics Stock history
CRISPR Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CRISPR is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CRISPR Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CRISPR Therapeutics stock prices may prove useful in developing a viable investing in CRISPR Therapeutics
CRISPR Therapeutics Stock Technical Analysis
CRISPR Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
CRISPR Therapeutics Period Price Range
Low | January 10, 2025
| High |
0.00 | 0.00 |
CRISPR Therapeutics AG cannot be verified against its exchange. Please verify the symbol is currently traded on Stuttgart Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
CRISPR Therapeutics January 10, 2025 Market Strength
Market strength indicators help investors to evaluate how CRISPR Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CRISPR Therapeutics shares will generate the highest return on investment. By undertsting and applying CRISPR Therapeutics stock market strength indicators, traders can identify CRISPR Therapeutics AG entry and exit signals to maximize returns
Additional Tools for CRISPR Stock Analysis
When running CRISPR Therapeutics' price analysis, check to measure CRISPR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CRISPR Therapeutics is operating at the current time. Most of CRISPR Therapeutics' value examination focuses on studying past and present price action to predict the probability of CRISPR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CRISPR Therapeutics' price. Additionally, you may evaluate how the addition of CRISPR Therapeutics to your portfolios can decrease your overall portfolio volatility.